Skip to content

LEXARIA BIOSCIENCE CORP.

LEXX

CIK 0001348362

← back to feed
Revenue (TTM)
$450.56K
+105.2% YoY Q2 Apr 2026
Net Income (TTM)
−$9.55M
−105.4% YoY Q2 Apr 2026
EPS Diluted (TTM)
−$0.49
−40.4% YoY Q2 Apr 2026
Gross Margin
81.7%
Q2 Apr 2026
Operating Margin
-2,114.5%
Q2 Apr 2026
Net Margin
-2,119.0%
Q2 Apr 2026
Free Cash Flow (TTM)
−$6.17M
Q2 Apr 2026
Cash
$5.1M
Q2 Apr 2026
Total Debt
—
Q2 Apr 2026
Shares Outstanding
24.79M sh
Q2 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings